Warning! GuruFocus detected
1 Severe warning sign
with EDSA.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Edesa Biotech Inc
NAICS : 325412
SIC : 3741
ISIN : CA85855A3029
Description
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 78.2 | |||||
| Equity-to-Asset | 0.54 | |||||
| Debt-to-Equity | 0.01 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 37 | |||||
| 3-Year EPS without NRI Growth Rate | 37 | |||||
| 3-Year FCF Growth Rate | 42.2 | |||||
| 3-Year Book Growth Rate | -55.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 40.67 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 64.3 | |||||
| 9-Day RSI | 56.74 | |||||
| 14-Day RSI | 53.97 | |||||
| 3-1 Month Momentum % | 25.63 | |||||
| 6-1 Month Momentum % | -26.47 | |||||
| 12-1 Month Momentum % | -43.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.09 | |||||
| Quick Ratio | 1.09 | |||||
| Cash Ratio | 0.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -19.6 | |||||
| Shareholder Yield % | -5.89 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -176.73 | |||||
| ROA % | -111 | |||||
| ROIC % | -274.41 | |||||
| 3-Year ROIIC % | -218.95 | |||||
| ROC (Joel Greenblatt) % | -10327.76 | |||||
| ROCE % | -178.69 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 6.49 | |||||
| EV-to-EBIT | -2.52 | |||||
| EV-to-EBITDA | -2.6 | |||||
| EV-to-Forward-EBITDA | -1.54 | |||||
| EV-to-Forward-Revenue | 5.15 | |||||
| EV-to-FCF | -3.11 | |||||
| Earnings Yield (Greenblatt) % | -39.68 | |||||
| FCF Yield % | -29.66 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:EDSA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Edesa Biotech Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.87 | ||
| Beta | 0.15 | ||
| 3-Year Sharpe Ratio | -0.29 | ||
| 3-Year Sortino Ratio | -0.51 | ||
| Volatility % | 62.66 | ||
| 14-Day RSI | 53.97 | ||
| 14-Day ATR ($) | 0.130056 | ||
| 20-Day SMA ($) | 2.313535 | ||
| 12-1 Month Momentum % | -43.44 | ||
| 52-Week Range ($) | 1.55 - 5.59 | ||
| Shares Outstanding (Mil) | 7.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Edesa Biotech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Edesa Biotech Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Edesa Biotech Inc Frequently Asked Questions
What is Edesa Biotech Inc(EDSA)'s stock price today?
The current price of EDSA is $2.40. The 52 week high of EDSA is $5.59 and 52 week low is $1.55.
When is next earnings date of Edesa Biotech Inc(EDSA)?
The next earnings date of Edesa Biotech Inc(EDSA) is 2025-05-09 Est..
Does Edesa Biotech Inc(EDSA) pay dividends? If so, how much?
Edesa Biotech Inc(EDSA) does not pay dividend.
Guru Commentaries on NAS:EDSA
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers